BTLA Protein (mFc Tag)
-
- Target Alle BTLA Proteine anzeigen
- BTLA (B and T Lymphocyte Associated (BTLA))
- Protein-Typ
- Recombinant
-
Spezies
- Human
-
Quelle
- Human Cells
- Aufreinigungstag / Konjugat
- Dieses BTLA Protein ist gelabelt mit mFc Tag.
- Verwendungszweck
- Recombinant Human B- and T-Lymphocyte Attenuator/BTLA/CD272 (C-mFc)
- Sequenz
- Lys31-Leu150
- Produktmerkmale
- Recombinant Human B-and T-Lymphocyte Attenuator is produced by our Mammalian expression system and the target gene encoding Lys31-Leu150 is expressed with a mFc tag at the C-terminus.
- Reinheit
- >95 % as determined by reducing SDS-PAGE.
- Endotoxin-Niveau
- < 1.0 EU per μg as determined by the LAL method.
- Top Product
- Discover our top product BTLA Protein
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Please refer to the printed manual for detailed information.
- Buffer
- Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.
- Lagerung
- 4 °C,-20 °C,-80 °C
- Informationen zur Lagerung
- Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
-
- Target
- BTLA (B and T Lymphocyte Associated (BTLA))
- Andere Bezeichnung
- B- and T-Lymphocyte Attenuator/BTLA/CD272 (BTLA Produkte)
- Synonyme
- BTLA Protein, BTLA1 Protein, CD272 Protein, A630002H24 Protein, B and T lymphocyte associated Protein, BTLA Protein, Btla Protein
- Hintergrund
-
Background: B- and T-Lymphocyte Attenuator (BTLA) is a single-pass type I membrane protein containing 1 Ig-like V-type (immunoglobulin-like) domain. BTLA expression is induced during activation of T cells, and BTLA remains expressed on Th1 cells but not Th2 cells. Like PD1 and CTLA4, BTLA interacts with a B7 homolog, B7H4. However, unlike PD-1 and CTLA-4, BTLA displays T-Cell inhibition via interaction with tumor necrosis family receptors (TNF-R), not just the B7 family of cell surface receptors. BTLA is a lymphocyte inhibitory receptor that inhibits lymphocytes during immune response. BTLA also is a ligand for tumor necrosis factor (receptor) superfamily, member 14 (TNFRSF14), also known as herpes virus entry mediator (HVEM). BTLA-HVEM complexes negatively regulate T-cell immune responses.
Synonym: B- and T-Lymphocyte Attenuator, B- and T-Lymphocyte-Associated Protein, CD272, BTLA
- Molekulargewicht
- 40.4 kDa
- Pathways
- Cancer Immune Checkpoints
-